[ Cluster A · Access Guide ]

Hereditary Cancer Testing — No Referral Required

You don't need a doctor's permission to know your cancer risk. How direct-to-consumer clinical-grade testing works, when insurance coverage under NCCN criteria might still be the smarter route, and exactly what happens from order to answer.

By Dr. Michael Okonkwo, Chief Medical OfficerMedically reviewed by Shawn Desai, MD, PhD, Lab Director & Medical DirectorPublished August 12, 2026 · Reviewed August 2026
[ 108-Gene Panel ][ 5–7 Day Results · 48-Hour Priority Available ][ Counselor Included ]

The Direct Access Model, Explained

[ No Referral Needed ]

Traditionally, hereditary cancer testing required a doctor’s referral, a genetics clinic appointment, and often months of waiting. Direct-to-consumer (DTC) clinical-grade testing changed that: you order the test yourself, collect a cheek swab at home with an FDA-cleared collection device, and receive a physician-ready report from a CLIA-certified lab. The lab quality is the same — what changed is who is allowed to start the process.

Step 1

Order Online, No Referral

No doctor’s order, no gatekeeping appointment. Order GeneCancer in minutes and a kit ships free to your door.

Step 2

Swab At Home

A two-minute cheek swab — no blood draw, no clinic visit. Mail it back in the prepaid envelope.

Step 3

Physician-Ready Results

Results in 5–7 days (48-hour priority available): ACMG-classified variants your doctor can act on, plus a genetic counselor session with every positive result.

When Insurance Still Applies

[ NCCN Criteria ]

Going direct does not mean insurance becomes irrelevant. If you meet NCCN testing criteria, your insurer may cover testing ordered through your own physician — it can be worth asking before paying out of pocket. NCCN criteria generally include:

Personal History
  • Breast cancer diagnosed at age 50 or younger
  • Ovarian, pancreatic, or metastatic prostate cancer at any age
  • Male breast cancer at any age
  • Triple-negative breast cancer at 60 or younger
Family History
  • Two or more close relatives with breast, ovarian, pancreatic, or prostate cancer
  • A known BRCA or other cancer-gene mutation in the family
  • Ashkenazi Jewish ancestry with breast, ovarian, or pancreatic cancer in the family
  • Colorectal or endometrial cancer before 50 in you or a close relative

If you meet these criteria, see our guide to insurance coverage for genetic testing and the BRCA test cost breakdown (CPT 81432/81433). Many people still choose the direct route for speed: no referral wait, transparent $499 pricing (or included in the $89/mo membership), and results in days, not months. HSA/FSA cards are accepted either way.

How The Gene Matrix Process Works

[ Order To Answers ]
[ 01 ]

Order GeneCancer

$499 one-time or included with the $89/month membership. Ships free, no referral required.

[ 02 ]

Swab & Return

Two-minute cheek swab with an FDA-cleared collection device. Prepaid return envelope included.

[ 03 ]

Lab Analysis

108 genes sequenced and interpreted in our CLIA-certified, ISO 15189 lab at up to 99.9% analytical accuracy.

[ 04 ]

Results + Counselor

Physician-ready report in 5–7 days (48-hour priority available). Board-certified genetic counselor session included with every positive result.

Skip The Referral. Keep The Rigor.

[ GeneCancer · 108 Genes ]

Clinical-grade hereditary cancer testing without the referral maze: 108 genes, CLIA-certified ISO 15189 lab, results in 5–7 days (48-hour priority available) at up to 99.9% analytical accuracy, counselor included. $499 one-time or $89/mo with all 11 tests ($59/mo billed annually, $712/yr). 30-day money-back guarantee.

[ HSA / FSA Eligible ][ Counselor Included ][ Free Shipping ]

Testing Without A Referral — FAQs

Yes. Direct-to-consumer clinical-grade testing is available in most states, and Gene Matrix tests are processed in the same CLIA-certified laboratories used for physician-ordered tests. The difference is the ordering model, not the laboratory quality. We always recommend sharing results with your physician — reports are formatted for clinical use.

It is worth asking. If you meet NCCN criteria, testing ordered by your physician may be covered by insurance — but it typically involves a referral, a genetics appointment, and prior authorization, which can take weeks to months. Many patients pay the transparent $499 direct price (or use the $89/mo membership) to skip the wait, then use their results to unlock covered follow-up care.

Yes, when the lab is clinical-grade. Gene Matrix reports come from a CLIA-certified, ISO 15189 laboratory with ACMG-classified variants — the same standards hospital genetics departments use. Some physicians will confirm a positive DTC result with a second clinical sample before surgery decisions, which is standard practice and inexpensive for a known variant.

Every positive result includes a session with a board-certified genetic counselor who walks you through NCCN-aligned next steps: enhanced screening, risk-reducing options, and family cascade testing. Your report is designed to be handed directly to your doctor.

Yes. $499 covers the kit, shipping both ways, the 108-gene analysis, the report, and counselor access — no hidden lab or interpretation fees. With the $89/month membership ($59/mo billed annually, $712/yr), GeneCancer and all 10 other tests are included, with quarterly reinterpretation as guidelines evolve.

Yes — HSA and FSA cards are accepted at checkout, and every order includes a CPT-coded receipt for reimbursement documentation. Every plan also includes a 30-day money-back guarantee.

Chief Medical Officer · Gene Matrix
Medically reviewed by Shawn Desai, MD, PhD, Lab Director & Medical Director · August 2026